Steve N. Slilaty - Feb 18, 2022 Form 4 Insider Report for Sunshine Biopharma, Inc (SBFM)

Role
Chief Executive Officer, Director
Signature
/s/ Steve N. Slilaty
Stock symbol
SBFM
Transactions as of
Feb 18, 2022
Transactions value $
-$99,000
Form type
4
Date filed
2/22/2022, 12:07 PM
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBFM Series B Preferred Stock Disposed to Issuer -$99K -990K -99% $0.10 10K Feb 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share.